Factors associated with dropout at 2 years post-initiation of treatment in the first episode of schizophrenia

Factors associated with dropout at 2 years post-initiation of treatment in the first episode of schizophrenia

Background:Prevention of new episodes during the first 2 years after a first episode of schizophrenia (FES) may delay treatment refractoriness and brain morphological changes over time. However, adherence to treatment is characteristically poor in these patients. Aim: The aim of this study was to ex...

Full description

Bibliographic Details
Main Authors:	Jebril M. Benelmokhtar, Bonginkosi Chiliza, Lebogang Phahladira, Robin Emsley, Laila Asmal
Format:	Article
Language:	English
Published:	AOSIS 2021-03-01
Series:	South African Journal of Psychiatry
Subjects:	adherence schizophrenia first episode dual diagnosis flupenthixol decanoate long acting injectable positive and negative syndrome scale
Online Access:	https://sajp.org.za/index.php/sajp/article/view/1657

Similar Items

Extrapyramidal side effects in first-episode schizophrenia treated with flupenthixol decanoate
by: Francois-Pierre Joubert, et al.
Published: (2021-01-01)

Augmentation of aripiprazole by flupenthixol decanoate in poorly responsive schizophrenia: a randomized clinical study
by: Saeed Shoja Shafti
Published: (2017-07-01)

A prospective study of cognitive deficits in first episode psychosis, and the response thereof to treatment with Flupenthixol Decanoate
by: Schoeman, Renata
Published: (2011)

Aripiprazole Long-Acting Injection During First Episode Schizophrenia—An Exploratory Analysis
by: Gloria Giordano, et al.
Published: (2020-01-01)

Differential of Frequency and Duration Mismatch Negativity and Theta Power Deficits in First-Episode and Chronic Schizophrenia
by: Yan-Bing Xiong, et al.
Published: (2019-03-01)

Which Subgroup of First-Episode Schizophrenia Patients Can Remit During the First Year of Antipsychotic Treatment?
by: Zhang Cheng, et al.
Published: (2020-06-01)

Attitudes toward long-acting injectable antipsychotics among patients with schizophrenia in Japan
by: Sugawara N, et al.
Published: (2019-01-01)

Latent Iron Deficiency as a Marker of Negative Symptoms in Patients with First-Episode Schizophrenia Spectrum Disorder
by: Sung-Wan Kim, et al.
Published: (2018-11-01)

Instruments measuring blunted affect in schizophrenia: a systematic review.
by: Sanja Kilian, et al.
Published: (2015-01-01)

Associations of premorbid adjustment with type and timing of childhood trauma in first-episode schizophrenia spectrum disorders
by: Anna M. Smit, et al.
Published: (2021-06-01)

Reductions in Complex Mismatch Negativity to Extra Tone Gestalt Pattern Deviance in First-Episode Schizophrenia
by: Dean F. Salisbury, et al.
Published: (2020-06-01)

Mismatch Negativity and Impaired Social Functioning in Long-Term and in First Episode Schizophrenia Spectrum Psychosis
by: Timothy K. Murphy, et al.
Published: (2020-06-01)

Functionally relevant basal ganglia subdivisions in first-episode schizophrenia
by: Khorram, Babak
Published: (2008)

Functionally relevant basal ganglia subdivisions in first-episode schizophrenia
by: Khorram, Babak
Published: (2008)

Functionally relevant basal ganglia subdivisions in first-episode schizophrenia
by: Khorram, Babak
Published: (2008)

Access to credible information on schizophrenia patients’ medication adherence by prescribers can change their treatment strategies: evidence from an online survey of providers
by: Shafrin J, et al.
Published: (2017-06-01)

Case study of first episode schizophrenia
by: Shinu K. Kuriakose
Published: (2020-12-01)

Symptoms at onset in first episode schizophrenia: Caregivers perspectives
by: Hema Tharoor, et al.
Published: (2015-01-01)

Testing the contributions of striatal dopamine loss to the genesis of parkinsonian signs
by: Vanessa Franco, et al.
Published: (2012-07-01)

Relationship between negative symptoms and neurocognitive functions in adolescent and adult patients with first-episode schizophrenia
by: Manli Huang, et al.
Published: (2016-10-01)

Prodrome of Paranoid Schizophrenia with Episodic Type of Course and Schizoaffective Structure of Manifest Episode
by: Alexander S. Bobrov, et al.
Published: (2014-06-01)

Depot preparation in schizophrenia: Indian outlook
by: Mohit Shah, et al.
Published: (2018-01-01)

Executive attention impairment in first-episode schizophrenia
by: Orellana Gricel, et al.
Published: (2012-09-01)

The role of shared decision-making in improving adherence to pharmacological treatments in patients with schizophrenia: a clinical review
by: Andrea Fiorillo, et al.
Published: (2020-08-01)

Impaired Emotional Self-Referential Processing in First-Episode Schizophrenia
by: Yanli Zhao, et al.
Published: (2021-04-01)

Real-life assessment of aripiprazole monthly (Abilify Maintena) in schizophrenia: a Canadian naturalistic non-interventional prospective cohort study
by: Sally Mustafa, et al.
Published: (2019-04-01)

Treatment patterns in Medicaid patients with schizophrenia initiated on a first- or second-generation long-acting injectable versus oral antipsychotic
by: Pilon D, et al.
Published: (2017-03-01)

The Association Between Cognitive Deficits and Clinical Characteristic in First-Episode Drug Naïve Patients With Schizophrenia
by: Xing-Jie Peng, et al.
Published: (2021-02-01)

Clinical Validity of Subjective Clinical Prognosis in First Episode Psychosis Schizophrenia Patients: An Analysis of Data from the European First Episode Schizophrenia Trial (EUFEST) Study
by: Matei VP, et al.
Published: (2020-05-01)

Real-world effectiveness of long-acting injections for reducing recurrent hospitalizations in patients with schizophrenia
by: Hye Ok Kim, et al.
Published: (2020-01-01)

Relationship between illness disability in patients with first-episode schizophrenia with caregivers' perception of their needs
by: Ragul Ganesh, et al.
Published: (2019-01-01)

Corrigendum: The Association Between Cognitive Deficits and Clinical Characteristic in First-Episode Drug Naïve Patients With Schizophrenia
by: Xing-Jie Peng, et al.
Published: (2021-04-01)

What happens after an oral ingestion of haloperidol decanoate? – A case report
by: João Perestrelo, et al.
Published: (2019-05-01)

A 12-Month Retrospective Analysis of Three Long-Acting Antipsychotic Injections in Patients with Schizophrenia: Comparison of Medication Adherence with Psychiatric Hospitalization Rates, Cost of Services, and Concomitant Medications
by: Chuc, Alan, et al.
Published: (2007)

Relationships between abnormal neural activities and cognitive impairments in patients with drug-naive first-episode schizophrenia
by: Wei Yan, et al.
Published: (2020-06-01)

Rediscovery of penicillin of psychiatry: haloperidol decanoate
by: Nazan Aydın, et al.
Published: (2019-07-01)

Characteristics of delayed and timely treatment seekers for first-episode schizophrenia in Thailand
by: Patcharapim Takizawa, et al.
Published: (2020-12-01)

Suicidal ideation and quality of life in patients with a first episode of schizophrenia
by: Krystyna Górna, et al.
Published: (2010-03-01)

Reduced Cell-Free Mitochondrial DNA Levels Were Induced by Antipsychotics Treatment in First-Episode Patients With Schizophrenia
by: Houxian Ouyang, et al.
Published: (2021-07-01)

Association between unmet needs and clinical status in patients with first episode of schizophrenia in Chile
by: Natalia eJorquera, et al.
Published: (2015-04-01)